Successful treatment of Mycobacterium abscessus infection with alternate-day half-dose linezolid: A case report and literature review
iCell · 2024
DOI: 10.71373/jpip5103 ↗Kurz gefasst
Fallbericht in der Zeitschrift iCell, 2024. Verfasst von Feng-yan Huang und 6 weiteren Autor:innen.
Abstract (Originalsprache)
Mycobacterium abscessus (Mab) is a common rapidly growing non-tuberculous Mycobacterium (NTM). On the basis of host immune deficiency (such as positivity for anti-IFN-γ autoantibodies), it can cause a variety of diseases, with pulmonary infection being the most common, followed by skin and soft tissue infections. Currently, the clinical treatment for Mab infections mainly relies on a multi-drug combination regimen centered around macrolides. However, due to the limited number of drugs active against Mab, along with a long treatment course, a high susceptibility to macrolide-induced resistance, and poor treatment compliance caused by adverse drug reactions, clinical treatment is challenging and it is difficult to achieve satisfactory therapeutic outcomes. This article reports a case of skin and soft tissue infection caused by Mab in a patient with a drug allergy constitution and multiple adverse drug reactions. During the maintenance treatment phase, after repeated adjustments to the anti-infective regimen, a treatment strategy was ultimately adopted: taking half the daily dose of linezolid (600 mg, qd) on odd-numbered days and the regular dose of linezolid (600 mg q12h) on even-numbered days, which led to successful treatment. After dose adjustment, the patient's skin lesions completely resolved, and no recurrence was observed during follow-up through December 31, 2025. No further severe myelosuppression occurred under the alternate-day half-dose regimen. Meanwhile, we reviewed relevant literature with the aim of exploring individualized treatment plans for Mab and providing reasonable treatment recommendations for clinicians.
Zitieren
APA
Huang, F., Liang, L., Yang, Y., Zhan, H., Wang, H., Cao, J., & Lv, J. (2024). Successful treatment of Mycobacterium abscessus infection with alternate-day half-dose linezolid: A case report and literature review. iCell. https://doi.org/10.71373/jpip5103
Vancouver
Huang F, Liang L, Yang Y, Zhan H, Wang H, Cao J, et al. Successful treatment of Mycobacterium abscessus infection with alternate-day half-dose linezolid: A case report and literature review. iCell. 2024. doi:10.71373/jpip5103
BibTeX
@article{Huang2024,
author = {Huang, Feng-yan and Liang, Liu-dan and Yang, Ying and Zhan, Hao and Wang, Hao and Cao, Jian-yu and Lv, Jian-nan},
title = {Successful treatment of Mycobacterium abscessus infection with alternate-day half-dose linezolid: A case report and literature review},
journal = {iCell},
year = {2024},
doi = {10.71373/jpip5103}
}
EUVIMED